About Oncology Nursing Drug Handbook
2018 Oncology Nursing Drug Handbook. Written especially for nurses caring for patients with cancer. Download the FREE app and view selected topics (Approximately 10% of the content is viewable in the free app and tapping...
2018 Oncology Nursing Drug Handbook. Written especially for nurses caring for patients with cancer. Download the FREE app and view selected topics (Approximately 10% of the content is viewable in the free app and tapping on the locked topic will launch the in-app purchase screen).
The 2018 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. Updated annually, this essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration.
Completely revised and updated, the 2017 Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA approved drugs.
New drugs include: alectinib (Alecensa), atezolizumab (Tecentriq), cabozantinib tablets (Cabometyx), cabozantinib capsules (Cometriq), cobimetinib tablets (Cotellic), colistin/polymixin B, clotrimazole, daratumumab (Darzalex), elotuzumab (Empliciti), irinotecan liposome injection (Onivyde), ixazomib (Ninlaro), melphalan for injection (Evoela), necitumumab (Portrazza), osimertinib (Targrisso), pentamidine, posaconazole, peramivir, rolapitant (Varubi) , talimogene laherparepvec (Imlygic), Tamiflu, trabectedin (Yondelis), uridine triacetate (Vistogard granules), venetoclax (Venclexta), vincristine liposome injection (Marqibo), and zanamivir.
Table of Content:
I Cancer Treatment
1 Introduction to Chemotherapy Drugs
2 Biologic Response Modifier Therapy
3 Cytoprotective Agents
4 Molecularly Targeted Therapies
5 Chemobiotherapy for Noncancer Diseases
II Symptom Management
6 Pain
7 Nausea and Vomiting
8 Anorexia and Cachexia
9 Anxiety and Depression
III Complications
10 Managing Tumor-Related Skeletal Events and Hypercalcemia
11 Infection
12 Constipation
13 Diarrhea
Appendix 1 : Occupational Exposure to Hazardous Drugs
Appendix 2 :Common Terminology Criteria for Adverse Events (CTCAE)
Author:
Gail M. Wilkes, MS, APRN-BC, AOCN-Oncology Nursing Consultant, Kilauea, Hawaii
ISBN-13: 9781284117189
ISBN-10:1284117189
Aug 17, 2020
Version 4.4.1
Fixes related to connecting to iTunes for in-app purchases in iOS version 13.4 and above
Previous Versions
Here you can find the changelog of Oncology Nursing Drug Handbook since it was posted on our website on 2023-09-06 17:35:39.
The latest version is 4.4.1 and it was updated on 2024-04-22 09:33:35. See below the changes in each version.
Oncology Nursing Drug Handbook version 4.4.1
Updated At: 2020-08-17
Changes: Aug 17, 2020
Version 4.4.1
Fixes related to connecting to iTunes for in-app purchases in iOS version 13.4 and above
Disclaimer
Official App Store Link
We do not host Oncology Nursing Drug Handbook on our servers. We did not scan it for viruses, adware, spyware or other type of malware. This app is hosted by Apple and passed their terms and conditions to be listed there. We recommend caution when installing it.
The App Store link for Oncology Nursing Drug Handbook is provided to you by apps112.com without any warranties, representations or guarantees of any kind, so access it at your own risk.
If you have questions regarding this particular app contact the publisher directly. For questions about the functionalities of apps112.com contact us.
